Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of delirium and sleep disturbance after elective open-heart surgery
IRCT20120910010800N18Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium and sleep disorder comparing Melatonin with Placebo (2 arms). Primary endpoints: Incidence of delirium and Sleep quality score. Started Jul 2026; status: completed.
02
Drugs
melatonin
03
Conditions
deliriumsleep disorder
Beyond the preview
Go deeper on IRCT20120910010800N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120910010800N18.